Janumet

Mer­ck, Vi­a­tris agree to set­tle patent feud sur­round­ing di­a­betes drugs
Mer­ck, Vi­a­tris agree to set­tle patent feud sur­round­ing di­a­betes drugs
Endpoints
Merck
Viatris
patents
diabetes
Januvia
Janumet
Flag link:
Merck discovers 'root cause' of nitrosamine levels in blockbuster diabetes drugs
Merck discovers 'root cause' of nitrosamine levels in blockbuster diabetes drugs
Endpoints
Merck
nitrosamine
diabetes
Januvia
Janumet
drug manufacturing
Flag link:
Merck pulls a patent win for diabetes franchise in West Virginia federal court
Merck pulls a patent win for diabetes franchise in West Virginia federal court
Endpoints
Merck
Januvia
Janumet
generics
legal
Viatris
Flag link:
Januvia and Janumet: An Update on Merck’s Diabetes Franchise after 2Q17
Januvia and Janumet: An Update on Merck’s Diabetes Franchise after 2Q17
Market Realist
Merck
diabetes
Januvia
Janumet
Flag link:
Merck's Diabetes Franchise And The Perils In Proving A Drug's Medical Value
Merck's Diabetes Franchise And The Perils In Proving A Drug's Medical Value
Forbes
Merck
diabetes
Januvia
Janumet
Eli Lilly
Flag link:
Merck inks pay-for-performance deal to boost diabetes drugs
Merck inks pay-for-performance deal to boost diabetes drugs
BioPharma Dive
Merck
pay-for-performance
diabetes
Janumet
Januvia
Aetna
Flag link:
What Are Merck’s Key Diabetes Products?
What Are Merck’s Key Diabetes Products?
Market Realist
Merck
diabetes
Januvia
Janumet
Flag link:
Januvia and Janumet: Merck’s Blockbuster Diabetes Drugs
Januvia and Janumet: Merck’s Blockbuster Diabetes Drugs
Yahoo/Market Realist
Merck
diabetes
Januvia
Janumet
Flag link:
Januvia and Janumet: Merck’s Blockbuster Diabetes Products
Januvia and Janumet: Merck’s Blockbuster Diabetes Products
Yahoo/Market Realist
Merck
Januvia
Janumet
diabetes
Flag link:
Merck notches another win in India patent battle over diabetes bestsellers
Merck notches another win in India patent battle over diabetes bestsellers
Fierce Pharma
Merck
India
patents
diabetes
Glenmark
Januvia
Janumet
Flag link:
Did This Clinical Study Just Show Merck's Best-Selling Drug the Door?
Did This Clinical Study Just Show Merck's Best-Selling Drug the Door?
Motley Fool
Merck
clinical trials
Januvia
Janumet
Eli Lilly
Boehringer Ingelheim
SGLT2 inhibitor
Jardiance
Flag link:
Merck’s Diabetes Dominance at Risk as Rival Drug Helps Out Heart
Merck’s Diabetes Dominance at Risk as Rival Drug Helps Out Heart
Bloomberg
Merck
Januvia
Janumet
diabetes
Jardiance
Eli Lilly
Boehringer Ingelheim
Flag link:
Merck scores victory in India patent battle over top diabetes meds
Merck scores victory in India patent battle over top diabetes meds
Fierce Pharma
Merck
India
patents
diabetes
Glenmark
Januvia
Janumet
Flag link:
FDA eases worries regarding certain diabetes medications
FDA eases worries regarding certain diabetes medications
Yahoo/Fly on the Wall
FDA
diabetes
Merck
Januvia
Janumet
Novo Nordisk
Victoza
Bristol-Myers Squibb
Byetta
Bydureon
Flag link:
Markets That Can Propel Merck
Markets That Can Propel Merck
Forbes
Merck
Gardasil
lambrolizumab
Janumet
Januvia
Flag link:
Avanir Pharma to co-promote Merck's diabetes drugs; shares rise
Avanir Pharma to co-promote Merck's diabetes drugs; shares rise
Reuters
Avanir
Merck
diabetes
Januvia
Janumet
Janumet XR
Flag link:
10 Top-selling Diabetes Drugs - 2012
10 Top-selling Diabetes Drugs - 2012
Fierce Pharma
diabetes
Merck
Januvia
Lantus
Sanofi
NovoRapid
Novo Nordisk
Eli Lilly
Humalog
Victoza
Levemir
Janumet
Novo Mix 30
Takeda
Actos
Flag link:
Merck's Dynamic Duo
Merck's Dynamic Duo
Motley Fool
Merck
Januvia
Janumet
diabetes
Flag link:
Merck Warned by FDA on Failure to Study Januvia Treatment for Side Effects
Merck Warned by FDA on Failure to Study Januvia Treatment for Side Effects
Bloomberg
FDA
Januvia
Merck
Janumet
diabetes
Flag link:
Merck Reports FDA Acceptance of NDA for Janumet
Merck Reports FDA Acceptance of NDA for Janumet
Bloomberg
Merck
FDA
Janumet
NDA
diabetes
Flag link:

Pages